4//SEC Filing
Hoberman Kenneth 4
Accession 0001104659-22-060913
CIK 0001875558other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:33 AM ET
Size
5.1 KB
Accession
0001104659-22-060913
Insider Transaction Report
Form 4
Hoberman Kenneth
Director
Transactions
- Purchase
Common Stock
2022-05-12$17.40/sh+6,000$104,400→ 55,140 total
Footnotes (1)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $17.16 to $17.66. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001573722
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:33 AM ET
- Size
- 5.1 KB